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Abstract  
Persistent Orofacial Pain (POFP) is common and caused by a group of conditions affecting 
the face, head or mouth. Recent research has highlighted a problematic care pathway with 
high costs to the healthcare provider, but the financial impact on patients and employers is 
not understood. This study aimed to describe patient (out-of-pocket) and employer (indirect) 
costs of POFP and identify whether the dichotomized Graded Chronic Pain Scale (GCPS) 
was predictive of costs.  
A cohort of 198 patients was recruited from primary and secondary care settings in the 
North-East of England and followed over a 24-month period. Patients completed GCPS and 
‘use of health services and productivity’ questionnaires every 6 months and a ‘time and 
travel questionnaire’ at 14 months.  Questionnaires examined the implications of healthcare 
utilisation on patients’ everyday lives and personal finances. Time and travel costs were 
calculated and applied to use of services data to estimate out-of-pocket costs, while the 
human capital method and ‘QQ method’ (Quantity and Quality of work completed) were used 
to estimate absenteeism and presenteeism costs respectively.  
Mean out-of-pocket costs were £333 (95%CI: 289 – 377) and indirect costs were £1242 
(95%CI: 1014 – 1470) per person per six-month period (in 2017 pounds sterling). 
Regression analyses indicated that over six months GCPS was predictive of both out-of-
pocket costs (a difference of £311 between low and high GCPS per person per six-month 
period, 95% CI: £280-342 ;p< 0.01, 705 observations over 24 months) and  indirect costs (a 
difference of £2312 per person per six-month period between low and high GCPS; 95% CI: 
£1886-2737, p<0.01, 352 observations over 24 months).  
This analysis highlights ‘hidden’ costs of POFP and supports the use of the dichotomized 
GCPS to identify patients at risk of higher impact and associated costs and thereby stratify 
care pathways and occupational health support appropriately. 
Keywords: chronic pain, facial pain, healthcare utilization, cost analysis, graded chronic 
pain scale, quality-of-life  
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Introduction  
Persistent Orofacial Pain (POFP) refers to a group of conditions affecting the face and 
mouth and includes:  temporomandibular disorders, burning mouth syndrome, persistent 
dentoalveolar pain, trigeminal neuralgia, and atypical facial pain (persistent idiopathic facial 
pain). A range of prevalence rates of POFP have been reported (Aggarwal et al. 2010; 
Goulet and Woda 2017; Horst et al. 2015; Macfarlane et al. 2001), and these figures, 
ranging from 5-14%, are suggestive that POFP is relatively common.  
Recent qualitative data from individuals experiencing POFP suggest problems with the 
existing care pathway (Breckons et al. 2017). This research describes how patients attend a 
large number of appointments with different healthcare professionals but fail to obtain 
effective diagnoses, treatment or referral for their pain. Research highlighting healthcare 
providers’ perspectives on POFP corroborate these findings as they suggest difficulties 
diagnosing and treating POFP (Aggarwal et al. 2011a; Aggarwal et al. 2011b; Durham et al. 
2007; Peters et al. 2015) in addition to service constraints including limited numbers of 
specialist services (Aggarwal et al. 2011a). Collectively these studies suggest a problematic 
care pathway from both provider and patient perspectives.  
Recent data have outlined costs associated with POFP from a health service provider’s 
perspective and suggested that pain related disability, as measured by the dichotomized 
Graded Chronic Pain Scale (Von Korff et al. 1992), is predictive of direct health service costs 
and thereby, as a proxy, of treatment need (Durham et al. 2016). These data have also 
suggested that health service costs are primarily driven by a high number of consultations.  
Whilst research is limited, there is some suggestion that for pain conditions similar to POFP, 
such as headache, a large proportion of costs are associated with reduced productivity at 
work, so called “presenteeism” (Linde et al. 2012). This is in contrast to a persistent pain 
condition such as lower back pain for which indirect costs may be comprised of a larger 
proportion of absence-related costs, i.e. “absenteeism” (Juniper et al. 2009). To our 
knowledge, no research has examined costs of POFP from the perspective of patients or 
employers which are important from a health policy perspective in order to understand the 
potential implications to the wider economy. The aim of this study was, therefore, to describe 
the indirect and out-of-pocket costs of POFP and determine whether dichotomized GCPS 
status is predictive of either of these. 
 
Methods 
Ethical approval for the study was obtained via the local research ethics committee (National 
Research Ethics Service reference 12/YH/0338). The full protocol of the study is available in 
open access format (Durham et al. 2014).  
Sample and recruitment 
A sample size calculation indicated that 200 participants were needed (α  = 0.05) to detect a 
moderate effect size of 0.4 (Cohen 1988) between groups using 2-tailed inferential statistics 
with 80% power. This sample size also allowed us to examine up to 30 predictors of costs 
using regression analyses at a moderate effect size (α = 0.05; β = 0.8) (Green 1991). The 
dichotomised graded chronic pain scale was the predictor of interest, having demonstrated 
prognostic value (Von Korff et al. 1992), and been shown to be predictive of health service 
costs in POFP (Durham et al. 2016). Participants were recruited from primary care 
(community) dental (n=10 dental practices) and medical practices (n=25 medical practices), 
secondary care (hospital/specialist) from a range of departments (neurology, oral medicine, 
oral and maxillofacial surgery, and restorative dentistry) in North-East England, and through 
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self-referral via healthcare and public advertisements. People were eligible for this study if 
they: 
- had experienced orofacial pain for three months or more,  
- screened positive using validated self-report screening instruments for 
musculoskeletal, neuropathic or vascular origin of pain, 
- were 18 or more years old  
- were able to provide informed consent and communicate complex constructs in 
English. 
The recruitment strategy was to recruit 240 patients in order to allow for an anticipated 20% 
attrition rate over the 2-year follow-up.  
Recruiting clinicians returned a proforma upon receipt of which the study team contacted 
patients by telephone to conduct a standardised, validated screening questionnaire. This 
screening tool (Gonzalez et al. 2011; Hapak et al. 1994) classified the origin of patients’ pain 
into: (i) musculoskeletal (ii) neuropathic/vascular (iii) combined. This screening method’s 
sensitivity and specificity has been previously reported for this study: musculoskeletal 
(sensitivity, 63.1%; specificity, 85.9%), neuropathic/ vascular (sensitivity, 66.3%; specificity, 
96.8%) (Durham et al. 2016). Upon positive screening patients were invited to participate in 
the study and the study team obtained written informed consent. Patients who screened 
negative were thanked for their time and did not take part in the study unless a specialist 
clinical diagnosis was available which indicated that the screening result was a false 
negative. 
Data collection 
Three instruments were used to collect data about out-of-pocket and indirect costs. These 
questionnaires are described here and examples are included in the Appendix (Figures 1 
and 2): 
1. Case report form (CRF): Upon entry into the study all participants completed a 
structured telephone interview with a trained interviewer at which they reported: 
demographic and socioeconomic details (education level, employment status, 
income, residential area); the details of their healthcare contacts and treatments 
received over the duration of their pain up to that point in time. Residential area was 
used to allocate an Index of Multiple Deprivation (IMD; official measure of deprivation 
in England (Department for Communities and Local Government 2015)). 
 
2. Use of services and productivity questionnaire [USPQ] (Thompson et al. 2001) 
completed at Baseline, 6, 12 18 and 24 months:  This is a two part questionnaire. 
Part one collects data on use of health services over the past 6 months: participants 
were asked to report how many times they had visited a list of different types of 
Healthcare Professionals (HCPs), and to report any out-of-pocket expenditure on 
over the counter medication, prescription charges, NHS dental treatment, private 
treatment and any additional costs attributable to POFP. Part two collects data on 
participants’ employment status, number of days contracted, and the number of days 
that individuals were either absent from (‘absenteeism’), or attended (‘presenteeism’) 
work with pain in the previous 6 months. The quality and quantity method (QQ 
method) (Brouwer et al. 1999) and work attendance with health problems scale from 
the health and labour questionnaire (Van Roijen et al. 1996) were incorporated into 
the USPQ (Figure 1, Appendix).  
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For the QQ method participants were asked to indicate on two numerical rating 
scales the quality and quantity of work performed while working with pain (anchored 
at 1 [Practically Nothing’/Very Poor Quality] and at 10 [Normal Quantity/Normal 
Quality]). The work attendance with health problems scale uses a list of six problems 
with a 4-point ordinal scale response indicating frequency (Appendix, Figure 3).  
3. Time and travel questionnaire (Thompson et al. 2001) completed at 14 months: 
Participants were asked to report, for all the HCPs they had visited, the distance, 
duration and their usual mode of transport to appointments and provide additional 
information such as whether they were accompanied by a companion or required 
childcare. Participants were also asked what their activity would have been if they 
had not been attending a HCP (Figure 2, Appendix). 
 
The Graded Chronic Pain Scale [GCPS] (Von Korff et al. 1992) was used to assess pain 
related disability at 0, 6, 12,18 and 24 months. Its summary score allows classification on a 
five-point ordinal scale from Grade 0 (Low intensity, Low disability) to Grade IV (High 
Disability, Severely Limiting). A dichotomized GCPS score (High [IV-IIb]; Low [IIa-0]) was 
then calculated from the five point ordinal scale using an algorithm developed by Dworkin et 
al (Dworkin et al. 2002).  
 
Data analysis 
Prior to data analysis, data were cross-checked by two researchers (MB & JD) and cleaned 
in order to remove errors, inconsistencies or unfeasible responses. Costs collected over the 
two year study period were all converted into 2012 prices (the year the study started) within 
the analysis, adjusted for inflation using the Consumer Price Index (CPI), a measure of 
change in  prices of goods and services over time  from the Office for National Statistics 
(procedure described in detail in Figure 4, Appendix). The resulting final costs were then 
converted to the latest price year using the most recent CPI figure available and are 
presented in the paper in 2017 pounds sterling. Costs were calculated by time point and 
then all cost data were pooled from all time points thereby allowing calculation of a mean 
cost per six-month period over the entire study. Discounting of costs was not required as we 
were examining average costs for a 6-month period only.   
 
Patient Out-of-pocket costs 
Out-of-pocket costs were the sum of the following three categories: 
(i) Treatment and assessment costs 
These costs related to fees individuals had to pay directly including: prescription 
charges, NHS dental costs, private treatment costs and over the counter 
medication. Participants reported these costs directly at each time point in the 
USPQ and values reported are the sum of the reported costs. 
(ii) Time and travel costs 
These consisted of travel costs to and from appointments (e.g. public transport, 
private vehicle, or taxi costs) and travel and appointment time costs (e.g. lost 
wages or leisure time). Data from the ‘time and travel questionnaire’ was used to 
calculate a unit cost per type of appointment for each patient (Figure 5, 
Appendix). Hourly and daily wages were calculated using annual salary 
information (from the CRF) and days worked per week (from USPQ). Standard 
UK values were used for mileage rates and leisure time (Figure 6, Appendix) 
(Douglas and Johnson 2004). This unit cost was then applied to the number of 
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appointments reported at each time point in the USPQ.  Companion costs (where 
reported) were calculated identically and added to the participant costs. 
(iii) Additional costs 
These consisted of any additional reported expenditure that patients attributed to 
their POFP.  
 
 
Indirect costs 
For the subsample of participants reporting being in employment, we estimated the cost to 
their employer due to absenteeism using the Human Capital method (Van den Hout 2010) 
that applies participant’s daily wage to the length of time they reported being absent. Costs 
related to presenteeism were calculated using the QQ method (Brouwer et al. 1999), details 
of which are provided in the Appendix (Figure 7).  
 
Statistical procedures 
All analyses were performed using STATA 13 (version 13; StataCorp LP). Descriptive 
statistics were calculated to describe mean and standard deviation values of costs. 
Parametric inferential statistical tests were used to examine the possible time effect on 
costs. Bootstrapping (bias-corrected accelerated method with 1000 repetitions) was used to 
produce confidence intervals around mean value. As appropriate for cost data with a skewed 
distribution (Julie and Simon 2004), generalised linear models (GLMs) using a log link 
function, were used to examine the relationship between dichotomised GCPS status and 
out-of-pocket costs and indirect costs, controlling for demographic and socioeconomic 
factors, including: age, gender, education level (no public examinations; secondary 
examinations; degree or higher), index of multiple deprivation (50% least deprived; 50% 
most deprived) and duration of pain at start of the study (less than 1 year, 1-4 years, 5 years 
or greater). Time point dummy variables were also included in the regression to control for 
any possible time effect.   
The size of the sample varied by time point and dropout/non-response is described in detail 
in Figure 1. Participants were included in this analysis if they returned both the USPQ and 
GCPS questionnaires. Missing data rates for respondents were low; across the time points 
the mean level of missing data for participants was between 2 and 6%. Missing data were 
imputed using UK reference costs and or mean/median imputation where appropriate 
(details and worked examples Appendix, Figure 8). This report follows the STROBE 
guidelines for reporting cohort studies (Von Elm et al. 2014) and the relevant points of the 
CHEERS checklist (Husereau et al. 2013). 
 
Results 
For the overall study 387 individuals were referred for screening and 279 agreed to be 
screened. Of those screened 268 screened positive and met inclusion criteria and 239 of 
these individuals agreed to participate (details of recruitment location in Table 1, Appendix). 
The consort diagram (Figure 1) demonstrates the flow of participants through the study. For 
this paper, patients were included in the analysis at a time point if they had returned GCPS 
and USPQ data. 
Out-of-pocket costs 
Table 1 demonstrates the sociodemographic details of the sample included in the analysis at 
each time point. The changing number of individuals at each time point represents those 
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who dropped-out, most frequently by non-response. Within a six-month period, the cohort 
reported a mean of 9 (SD 12) healthcare appointments. Table 2 demonstrates their total out-
of-pocket costs per person per six-month period for these visits as well as treatment and 
assessment costs incurred due to POFP (Mean £333 [95%CI: 289; 377]).  
The total number of observations in the GLM regression (Table 2, Appendix) was 705 over 
the 5 time-points due to missing sociodemographic data. The regression indicated that those 
with a high GCPS (n=227) had increased out-of-pocket costs; those with a low GCPS 
(n=478) had mean out-of-pocket costs of £240 (95%CI 230; 250) and those in the high 
GCPS had mean out-of-pocket costs of £551 (95% CI 522; 581); and the difference in cost 
between groups was a mean of £311 (95% CI: 280; 342 ; P < 0.01) per person per six-
month period. Whilst out-of-pocket costs did not differ significantly between M0 and M6, at 
M12, M18 and M24 out-of-pocket costs were significantly less than baseline (F(4, 785) = 
4.90; p<0.01) (Figure 9, Appendix).  
Indirect costs 
At each of the time points around half (range 48.5 – 51.7%, Appendix Table 3) of the 
participants reported being employed. Those employed, reported missing a mean of 1.7 (SD 
= 5.9) days over a six-month period due to their POFP. This absenteeism equated to an 
employer cost of £174 (95% CI: 113; 236) per person per six-month period (Table 4). Those 
employed reported attending work with pain for a mean of 34.6 (SD = 42.9) days per six-
month period. The QQ method suggested a mean decrease over the 24 months of 
observations of 17.4% (SD=20.7) in the quantity (mean 8.3 out of 10 [SD=2.1]), and 16.9% 
(SD = 18.8) in the quality (8.3 out of 10 [SD=1.9]), of work completed whilst in pain. These 
reported losses were used to estimate mean employer costs of £1068 (95% CI: 849; 1287) 
per person per six-month period due to presenteeism. The most commonly reported problem 
facing individuals whilst at work was ‘problems concentrating’ (73%) due to POFP followed 
by ‘decision making’ (59%) (Appendix, Figure 3). 
The total number of observations in the GLM regression over the 5 time-points (Table 4, 
Appendix) was 352 due to missing sociodemographic data. The regression demonstrated 
that those with a high GCPS status (n=101) had higher indirect costs; those with a low 
GCPS (n=251) had mean indirect costs of £681 (95%CI 631; 730) and those in the high 
GCPS (n=101) had mean indirect costs of £2992 (95% CI 2575; 3410); the difference in 
costs between the groups was £2312 (95% CI: 1886; 2737 ; P < 0.01) per person per six-
month period. Although the employer costs did not differ significantly over the first four time-
points (Appendix, Figure 10), M24 patient costs were significantly less than M6 costs 
(F(4,390) = 3.42: p<0.01). 
 
Discussion  
 
This analysis builds on work examining costs of POFP (Durham et al. 2016) and suggests 
that in addition to health service costs, there are also considerable out-of-pocket and indirect 
costs to be considered that fall on patients, their families and employer. Research in other 
conditions has highlighted the burden on the individual caused by financial demands of a 
chronic condition (Piette et al. 2004). Additionally, our data highlight a need to ensure 
presenteeism is assessed as otherwise absenteeism taken in isolation may underestimate 
the impact of persistent pain conditions on the workforce. 
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These data suggest that the GCPS may have predictive value in identifying those who are 
likely to incur high out-of-pocket and indirect costs and thus be at risk of the impact of these 
additional costs. This analysis also suggests that in addition to the potential of the 
dichotomized GCPS to predict higher healthcare costs it may be a useful screening tool for 
determining who is at risk of incurring the highest out-of-pocket costs and having their work 
affected by their pain. The most common problems affecting individuals whilst at work with 
POFP were difficulties concentrating and making decisions alongside having to work at a 
slower pace.  
The GCPS represents a way to screen those who are in the greatest need of occupational 
health support whilst continuing ongoing management for their POFP. It may be possible 
then, as in other similar pain conditions such as migraine, to institute simple logistical, 
educational, or pacing interventions that will help improve the quality of work and work 
environment for those experiencing POFP thereby improving productivity and reducing the 
effect of presenteeism (Berry 2007; McLean 2009; Parker and Waltman 2012; Vicente-
Herrero et al. 2004). There are, however, no data currently available on what measures 
would be sensible to help those experiencing POFP whilst at work and this is an area for 
further research. 
Our previous quantitative and qualitative research (Breckons et al. 2017; Durham et al. 
2016) have highlighted the large number of appointments that individuals attend in an 
attempt to obtain a diagnosis and treatment for their POFP. This difficult and convoluted care 
pathway increases both the distress to the patient and cost to the health service.  Data from 
the current study also demonstrate its wider economic impact. Durham et al have previously 
suggested a stratified system may offer advantages over the current system (Durham et al. 
2016) and this study provides further support for the idea of such a pathway.  
There are several limitations to this study: with regard to the size and selection of the cohort, 
we have recruited from a single region of the UK and therefore we do not know how 
generalizable our results are. Additionally, while we recruited people who had experienced 
POFP for varying lengths of time, given that the data suggested a possible temporal 
downward trend in both out-of-pocket and indirect costs it would be of further interest to 
investigate costs beyond the duration of the study to provide a clearer picture of longer term 
implications to patients and employers. While the level of missing data was generally low, as 
with all treatment of missing data, imputation and assumptions of questions being non-
applicable have the potential to under or overestimate costs. In addition, study dropout 
always has the potential to introduce selection bias. 
In summary, POFP is known to have a profound and debilitating impact on people’s lives 
and this paper has highlighted ‘hidden’ costs of the condition. Future work should focus on 
how care pathways can be designed to better meet the needs of patients. Given the high 
levels of presenteeism and the potential financial impact on employers further research on 
how people experiencing POFP can be supported at work is warranted. 
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Figure 1. Consort Diagram showing patient flow over the 2 year follow up period 
 
1There was no significant difference in age, gender or origin of pain between positively 
screened patients who participated and those who declined (P>0.05). 
2There were no significant differences in gender, ethnicity, duration of pain or origin of pain 
between those dropping out and the 198 participants whose data was included in the study 
(p>0.05). However those participating were significantly older than those who dropped out 
(p<0.01). 
3One patient withdrew from the study at M18 and requested that their data be withdrawn. 
4Data was not received from 3 participants at M0 who reported returning data but this was 
not received by the study team. These patients returned data at subsequent time points. 
13 
 
5There was no significant difference between those dropping out at M6 and the M0 sample 
on the basis of: Age, Gender, Ethnicity, Duration of pain or Origin of pain (P>0.05). 
6There was no significant difference between those dropping out at M12 and the M0 sample 
on the basis of: Age, Gender, Ethnicity or Origin of pain (P>0.05) although those dropping 
out had a significantly longer duration of pain to those participating at baseline (P<0.05). 
7One of these patients went on to complete data at a further time point. 
8There was no significant difference between those dropping out at M14 and the M0 sample 
on the basis of: Age, Gender, Ethnicity, Duration of pain or Origin of pain (P>0.05). 
9Three of these patients went on to return data at subsequent time points. 
10There was no significant difference between those dropping out at M18 and the M0 sample 
on the basis of: Age, Gender, Duration of pain or Origin of pain (P>0.05), although those 
dropping out consisted of a greater proportion of a White British ethnic group than those 
participating at baseline (P<0.01). 
11There was no significant difference between those dropping out at M24 and the M0 sample 
on the basis of: Age, Gender, Duration of pain or Origin of pain (P>0.05), although those 
dropping out consisted of a greater proportion of a White British ethnic group than those 
participating at baseline (P<0.01). 
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Table 1. Sociodemographic information of the sample analysed at each time point 
 
Sociodemographic 
Characteristic  
Time point 
M0 
(n=198) 
M6 
(n=172) 
M12 
(n=155) 
M14 
(n=141) 
M18  
(n=136) 
M24  
(n=129) 
Females, n (%) 160 (80.8) 139 (80.8) 127 (81.9) 113 (80.1) 110 (80.9) 106 (80.9) 
Age, mean years (SD) 
51.8 (16) 52.3 (15.6) 53.0 (14.9) 53.2 (14.8) 53.7 (14.7) 53.5 (14.6) 
Ethnic origin, n (%)     
   
 
White, British  158 (79.8) 137 (79.7) 122 (78.7) 107 (75.9) 104 (76.5) 100 (77.5) 
White, any other white 
background  1 (0.5) 1 (0.6) 0 (0) 1 (0.7) 0 (0) 0(0) 
Black, black British, or 
African  1 (0.5) 1 (0.6) 1 (0.7) 1 (0.7) 1 (0.7) 1 (0.8) 
Other, Chinese   1 (0.5) 1 (0.6) 1 (0.7) 1 (0.7) 1 (0.7) 0 (0) 
Other, not known  4 (2) 3 (1.7) 3 (1.9) 3 (2.1) 3 (2.2) 3 (2.3) 
Not provided  7 (3.5) 6 (3.5) 5 (3.2) 6 (4.3) 5 (3.7) 4 (3.1) 
Missing data  26 (13.0) 23 (13.4) 23 (14.8) 22 (15.6) 22 (16.2) 21 (16.3) 
Highest educational level 
n (%) 
  
    
 
University, postgraduate 
degree or diploma  22 (11.1) 20 (11.6) 19 (12.3) 18 (12.8) 16 (11.8) 15 (11.6)  
University, undergraduate 
degree or diploma  54 (27.3) 47 (27.3) 42 (27.1) 38 (27.0) 38 (27.9) 37 (28.7) 
Vocational qualifications  43 (21.7) 38 (22.1) 35 (22.6) 30 (21.3) 28 (20.6) 29 (22.5) 
Secondary school public 
examinations  39 (19.7) 33 (19.2) 26 (16.8) 25 (17.7) 24 (17.65) 22 (17.1) 
No public examinations  23 (11.62) 19 (11.1) 18 (11.6) 16 (11.4) 16 (11.8) 14 (10.9) 
Missing data  17 (8.6) 15 (8.7) 15 (9.7) 14 (9.9) 14 (10.3) 12 (9.3) 
IMD decile ranking of 
home postcode, n (%)a 
  
    
 
9 and 10 (least deprived 
areas of the United 
Kingdom)  29 (14.7) 23 (13.4) 16 (10.3) 16 (11.4) 15 (11.0) 14 (10.9) 
7 and 8  39 (19.7) 31 (18.0) 26 (16.8) 27 (19.1) 26 (19.1) 26 (20.2) 
5 and 6  31 (15.66) 30 (17.5) 29 (18.7) 24 (17.0) 24 (17.7) 22 (17.1) 
3 and 4  44 (22.2) 39 (22.7) 37 (23.9) 32 (22.7) 32 (23.5) 30 (23.3) 
1 and 2 (most deprived 
areas of the United 
Kingdom  52 (26.3) 48 (27.9) 45 (29.3) 40 (28.4) 37 (27.21) 36 (27.9) 
Missing data  3 (1.5) 1 (0.6) 2 (1.3) 2 (1.42) 2 (1.5) 1 (0.8) 
Employmentb  %       
Groups 1-3c 59 54 52 48 45 46 
Groups 4-6c 39 35 26 23 23 22 
Groups 7-9c 18 17 17 15 15 13 
Unemployed 27 22 19 16 15 13 
15 
 
Retired 44 35 33 33 32 29 
Sick leave due to POPF 2 2 2 2 2 2 
Student 5 3 2 2 2 2 
Missing data 4 4 4 2 2 2 
 
aThe Index of multiple deprivation describes relative deprivation in small geographical areas 
in England. 
bThe number reporting employment differed between the initial case report form (CRF) and 
the data provided in the Use of Services and Productivity Questionnaire (USPQ). The above 
table is based on the CRF data as this contained further details about employment status but 
the analysis in this paper is based on USPQ data which represented the dynamic status of 
employment. 
cEmployment type was categorised using Major groups from the UK Office for National 
Statistics Standard Occupational Classification 2010. Groups are as follows: 1, Managers, 
directors and senior officials; 2, Professional occupations; 3, Associate professional and 
technical occupations; 4, Administrative and secretarial occupations; 5, Skilled trades 
occupations; 6, Caring, leisure and other service occupations; 7, Sales and customer service 
occupations; 8, Process, plant and machine operatives; 9, Elementary occupations.  
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Table 2. Mean out-of-pocket costs in pounds sterling per 6 month period  
Time point Mean treatment and 
assessment. Costs in 
2017 pounds sterling 
(95% CI) 
Mean time and  travel 
costs in 2017 pounds 
sterling (95% CI) 
Mean total cost to 
individual in 2017 
pounds sterling (95% 
CI) 
M0  
 
229 (158; 300) 253 (182; 325)  482 (348; 617) 
M6  
 
 160 (97; 222)  177 (141; 212) 336 (260; 412) 
M12  
 
159 (97; 221)  153 (118; 187) 312 (233; 390) 
M18  
 
109 (59; 160)  116 (87; 144)  225 (166; 284) 
M24  
 
102 (71; 132)  135 (95; 175) 237 (178; 295) 
Pooled 
sample  
159 (132; 186)  174 (153; 195)  333 (289; 377) 
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Table 3. Estimates from GLM regression models (log link function) of the difference in 
costs between low and high GCPS status.  
 
Variable Change in cost in 
2017 pounds sterling 
(95% CI) 
Mean out-of-pocket 
costs in Low GCPS 
group in 2017 
pounds sterling 
(95% CI)  
Mean out-of-pocket 
costs in High GCPS 
group in 2017 pounds 
sterling (95% CI) 
Out-of-pocket costs 
[Total of 705 observations: 
478 in low GCPS; 227 in 
high GCPS] 
311  
(280; 342) 
240  
(230; 250) 
 
551  
(522; 581)  
 
Indirect costs 
[Total of 352 observations: 
251 in low GCPS; 101 in 
high GCPS] 
2312  
(1886; 2737)  
681  
(631; 730)  
2992  
(2575; 3410)  
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Table 4. Mean Indirect costs per 6 month period  
 
 
  
Time point Days 
absent due 
to POFP 
(SD) 
Absenteeism cost 
in 2017 pounds 
sterling (95% CI) 
Days present 
with POFP 
(SD) 
Presenteeism cost 
in 2017 pounds 
sterling (95% CI) 
Total 
Employer cost 
in 2017 
pounds 
sterling 
M0 (n= 97) 3.0 (8.2)  308 (112; 505) 44.3 (50.1)  1341 (866; 
1815) 
 1649 (1147; 
2151) 
M6 (n= 89) 2.4 (7.8)  253 (87; 418) 36.8 (43.7)  1455 (851; 
2058) 
1707 (1113; 
2301) 
M12 (n= 80) 0.6 (1.5)  60 (25; 95) 33.0 (39.3)  925 (486; 1363)  985 (538; 
1432) 
M18 (n= 66) 0.6 (1.5)  62 (24; 100) 23.9 (32.3)  775 (405; 1145)  837 (444; 
1231) 
M24 (n= 63) 1.2 (4.1)  119 (13; 225) 30.2 (41.3)  590 (315; 865) 709 (362; 
1056) 
Pooled sample 
(395 
observations) 
1.7 (5.9)  174 (113; 236) 34.6 (42.9)  1068 (849; 
1287) 
 1242 (1014; 
1470) 
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Figure 1 Extract from Use of Services and Productivity Questionnaire (USPQ) to give 
example of questioning style and context to data 
SECTION 1: CONSULTATIONS IN LAST 6 MONTHS 
Over the last six months how many times have you visited the practitioners listed below and have 
you had to pay for the attendance? Please write the number of times in the relevant box below. 
Please give details of the hospital dental or medical specialties that you have visited for example: 
restorative dentistry, rheumatology etc. Please indicate if it was a private consultation ie paid for by 
yourself outside of the NHS. Please give the total private or NHS charges you had to pay for the 
consultation(s). Please do not include any prescription charges, just those for having the consultation.  
… 
Question 1.2 Visits to a General Dental Practitioner 
Have you seen a general dentist?  Yes     No (move to question 1.3)  
If yes, did you see them as an NHS patient? Yes     No  
How many times did you see the dentist?   
If you had to pay anything for your dental appointments, how much have you paid in total over the last 
six months?  £ - p 
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Figure 2 Extract from Time and Travel questionnaire to give example of questioning 
style and context to data 
Section 1 PATIENT TRAVEL COSTS 
This first part of the questionnaire asks about the costs of your travel and attendance at any of the 
following health care practitioners: General Medical Practitioner, General Dentist, Physiotherapist, 
Psychologist, Hospital dental specialist, Hospital medical specialist, Alternative therapy for example: 
chiropractor, osteopath, and acupuncturist. 
Question 1.1 
Have you ever visited any of the following healthcare practitioners regarding your pain in your mouth 
and or face? Please tick those that you have seen. 
General Medical Practitioner   
General Dentist    
Physiotherapist    
Psychologist     
Hospital dental specialist   Please give details of the specialties seen: 
Hospital medical specialist   Please give details of the specialties seen: 
 
Question 1.2 
Please complete parts A-H below for any practitioners you have indicated that you have seen in 
question 1.1 regarding your pain in your mouth and or face. Please give only one mode of transport 
per practitioner. If you have seen more than one practitioner with respect to your pain eg: 2 hospital 
specialists, put the additional details in part h “other”. 
A) ATTENDANCE AT GENERAL MEDICAL PRACTITIONER: 
What was your normal mode of transport? 
Walk/cycle     
Ambulance/hospital car     
Public transport (bus, train, metro)   Cost of one way fare £ - p 
Taxi       Cost of one way fare £ - p 
Private car/motorbike     How many miles was a one way trip?  
 
What was your normal travelling time? 
Travelling time  hrs:  mins 
 
What was the normal time spent at the general medical practitioner’s surgery? 
Time spent at surgery  hrs:  mins 
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Did someone normally go with you to your appointment? 
No    
 
Yes    
If Yes, please indicate who normally went with you to the practitioner below. You may tick more than 
one box if appropriate: 
Partner/spouse   
Child/children under 16 years   
Other relative   
Paid caregiver   
Other (please specify)   Details:……………………………………………. 
 
  
23 
 
Figure 3 Work attendance with health problems scale (Van Roijen et al. 1996) - 395 
observations over 5 time points 
 
Problems experienced at work as a result of POFP were converted from a 4-point ordinal 
scale response indicating frequency of problems (almost never, sometimes, often, almost 
always) to a dichotomized format (i.e. never or ever experienced problems) and pooled to 
provide a cumulative frequency of the employed subsample who had ever experienced the 
individual problem. 
  
0% 20% 40% 60% 80% 100%
Problems concentrating at work
Working at a slower pace
Seclude themselves
Decision making
Put off work
Others take over
Number of respondents who experienced problems in these areas at any time point
Number of respondents who experienced no  problems in these areas
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Figure 4 Adjusting for inflation procedure and worked example 
Adjustment for inflation was applied so that all costs are given in 2012 prices. While 
calculation of many costs was based on 2012 reference costs (e.g. mileage rate, average 
income and valuation of leisure time) and adjustment for inflation was not necessary; other 
costs reported in questionnaires were comprised of actual expenditure e.g. public 
transport/taxi costs, out of pocket medication costs, consultation and treatment costs and 
therefore adjustment for inflation was required to convert these to 2012 prices. The 
adjustment for inflation method applied used Consumer Price Inflation from the Office for 
National Statistics (Office for National Statistics 2017) with the following rates of inflation:  
Year CPIH % change over 12 months 
2013 2.3 
2014 1.5 
2015 0.4 
2016 1.0 
2017 2.6 
 
These were applied based on when an individual joined the study, for example if a patient 
joined the study in 2012 their M0 and M6 were considered to be in 2012 prices, their M12, 
M14 and M18 were considered to be in 2013 prices and their M24 questionnaire to be in 
2014 prices. For example if this patient reported an out of pocket expenditure on over-the-
counter medication of £12 in their M12 use of services questionnaire, this was considered to 
be in 2013 prices and to convert to 2012 prices the relevant adjustment was applied as 
follows: 
12 x (1/1.023) = £11.73 
If the same individual, in their M24 questionnaire, reported expenditure on over-the-counter 
medication of £18, this was considered to be in 2014 prices and the following calculation 
was used to convert this to 2012 prices. 
18 x (1/1.015) x (1/1.023) = £17.34  
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Figure 5 Worked example of a patient appointment unit cost for a patient attending 
their General Dental Practitioner for their POFP 
Information provided by patient in time and travel questionnaire: 
Normal mode of transport: Private car 
Number of miles for one way trip: 6 
Travelling time: 50 minutes 
Time spent at surgery: 30 minutes 
Accompanied to appointment: No  
Was required to arrange childcare or care for dependents: No 
Main activity if not attending appointment: Leisure activities 
  
Cost calculation based on information provided above: 
Travel cost: 
6 miles x 2 journeys (for return journey) x £0.45 (HMRC mileage allowance) = £5.40 
Time cost: 
50mins (travelling time) + 30mins (appointment time) = 80 mins = 1.33 hours 
1.33hrs x £5.16 (U.K. Government’s Department of Transport value hourly time 
value for non-working individuals) = £6.86 
 
Total appointment cost to patient = £5.40 + £6.86 = £12.26 
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Figure 6 UK Reference Costs 
The following costs were used when calculating costs for patient time and travel: 
 For private vehicles, the UK’s Her Majesty’s Revenue and Customs (HMRC) 2012 
mileage rate of £0.45 per mile was used (HM Revenue & Customs 2013). 
 Leisure time was valued at £5.16 using the Department of Transport’s hourly time 
value for non-working individuals (Department for Transport 2015). 
 For the calculation of individual’s daily and hourly wages; in a six month period there 
were considered to be 26 working weeks and therefore in a month there were 4.33 
weeks.  
 In the case of incomplete employment data, a 2012 average UK hourly wage of 
£12.77 was used (Office for National Statistics 2016). For the generation of an 
average daily wage a working day was considered to last 7.5 hrs. 
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Figure 7 Calculating presenteeism costs using the QQ method 
The QQ method, as described by Brouwer (Brouwer et al. 1999) was used to estimate the 
productivity loss using the quality and quantity data from the use of services and productivity 
questionnaire. Quality and Quantity were reported by respondents on a 0-10 scale where 10 
was usual quality and 0 indicated very poor quality.  
If a respondent who worked for 8 hrs a day reported 7 out of 10 on the quantity scale and 6 
out of 10 on the quality scale the calculation was as follows. 
Quantity loss (hrs) = (1-7/10) x 8 = 2.4hrs 
Quality loss is calculated in the same manner, however before calculating the quality loss, 
the quantity loss is subtracted from the time worked i.e. we assume that the respondent 
worked the equivalent of 8-2.4 = 5.6hrs. 
Quality loss (hrs) = (1-6/10) x 5.6 = 2.24hrs 
The final QQ score is the sum of the quantity and quality loss calculated = 4.64hrs per day. 
This value is multiplied by the number of days that the respondent reported working while 
experiencing pain and multiplied by their hourly rate of pay to estimate the total cost of 
presenteeism. 
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Figure 8 Imputation procedures and worked examples 
Management of this missing data was as follows:  
Missing salary data were substituted by UK average values. 
Missing time and travel data were not imputed at an item level as these were used to inform 
mean unit costs applied to patients with missing time and travel data (see example 1 below), 
However if a patient’s partially complete data was greater than the mean unit cost value then 
this was used in preference to the mean unit cost. 
Missing use of services and productivity data were assumed to be non-applicable where 
questions were left completely blank and hence a zero value was used. Where questions 
were partially completed (e.g. a respondent had indicated they incurred a cost but did not 
provide the amount) mean imputation was performed, at an item level. Median imputation 
was performed for categorical variables (those describing problems experienced at work). 
Example 1. Imputation using average unit cost 
A patient’s total time and travel costs are the sum of the cost of their attendance at each of 
the healthcare professionals that they were asked about in the USPQ. If a patient had not 
provided information about a specific practitioner in the time and travel questionnaire then 
the average value of visits to that practitioner was used. For example, in their 18M USPQ, if 
a patient reported attending 3 GP appointments, 2 GDP appointments and 1 Physiotherapist 
appointment in the past in the previous 6 months, but had only provided time and travel 
information about their GDP (£3.60 per appointment) and Physiotherapist (£10.80 per 
appointment) in the Time and Travel questionnaire, then the mean value for a GP 
appointment (£11.62) was used. This patient’s time and travel cost would be as follows: 
Time and travel costs per 6 months at 18M: 
 = GP appointment cost x 3 + GDP appointment cost x2 + Physiotherapist appointment x1 
= £11.62 x 3            +     £3.60 x2                    + £10.80 x1 
= £52.86 per 6 month period. 
Example 2. Imputation using average number of appointments 
Similarly to the above example a patient may have indicated in their 14M month 
questionnaire that their time and travel costs for a GP visit was £5.60 and in their 12M 
questionnaire indicated that they had visited their GP in the previous 6 months but did not 
indicate how many times, this value was imputed using the mean number of GP 
appointments at that time point (4.4). Cost was then calculated using the imputed number of 
visits multiplied by the cost of their appointment. 
= £5.60 x 4.4  
= £24.64 
Example 3. Imputation using average wage 
A patient’s indirect costs (through absenteeism or presenteeism) are the sum of the time lost 
from work. If a patient had a QQ score (see calculation in Figure 5) of 4.64hrs per day, 
reported experiencing pain at work for 18 days in the previous 6 months, but had declined to 
provide income details in their CRF then the average UK average wage was used (£12.77): 
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Presenteeism cost per 6 month period = QQ score x hourly wage x days worked while in 
pain. 
= 4.64 x £12.77 x 18  
= £1066.55 presenteeism cost per 6 month period 
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Figure 9 Patient out of pocket costs over the 5 study time points 
 
 
*A one way ANOVA and Bonferroni post-hoc test suggested significant differences between 
M0 and M12, M18 and M24 costs: (F(4, 785) = 4.90; p<0.01). Error bars represent 95% 
confidence interval of the mean cost at each time point. 
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Figure 10 Employer indirect costs over the 5 study time points  
 
*A one way ANOVA and Bonferroni post-hoc test suggested significant differences between 
M6 and M24 costs: (F(4,390) = 3.42 p<0.01). Error bars represent 95% confidence interval 
of the mean cost at each time point. 
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Table 1 Recruitment location of those recruited at baseline1 
Recruitment location 
Recruited from clinic Recruited by 
advertisement2 
Total Total 
 N % N % N % 
General Medical 
Practice 49 24.3 21 58.3 70 29.4 
General Dental 
Practice 32 15.8 15 41.7 47 19.7 
Total primary 
(community, non-
specialist) care 81 
40.1 
 36 100 117  
Oral and Maxillofacial 
Surgery 40 19.8 - - 40 16.8 
Oral Medicine 13 6.4 - - 13 5.5 
Neurology/surgery 23 11.4 - - 23 9.7 
Restorative dentistry 
(Prosthodontics, 
periodontics, 
endodontics) 45 22.3 - - 45 18.9 
Total 
secondary/tertiary 
(specialist) care 121 59.9 0 0 121  
Total of all patients 202 100 36 100 238 100 
 
1 The one individual who withdrew their data at M18 is not included in this table therefore 
total is 238 instead of 239 
2 The advertisement was placed in primary care locations, local student halls of residence, 
university leisure centers, a local museum and several local pharmacies. Patients were 
classified based on their reported most recent use of health services. 
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Table 2 Generalized Gamma Linear Regression Model (Log Link Function) of factors 
associated with out of pocket costs (705 observations over 5 time points) 
Variable Coefficient  
95% Confidence 
Interval p value 
Dichotomized  GCPS* 
state (low, 0 to IIa; 
high, IIb to IV) 
(reference category: Low 
GCPS)    
High GCPS 0.78 0.57 0.99 <0.01 
Time point (reference 
category: 0M) 
 
   
6M -0.28 -0.56 -0.01 0.05 
12M -0.36 -0.64 -0.08 0.01 
18M -0.66 -0.95 -0.36 <0.01 
24M -0.53 -0.83 -0.22 <0.01 
Age Group, years 
(reference category: 20-
29) 
 
  
30-39 0.11 -0.35; 0.58 0.63 
40-49 -0.11 -0.56; 0.34 0.64 
50-59 0.03 -0.42; 0.49 0.88 
60-69 0.55 0.10; 1.00 0.02 
70-79 0.27 -0.23; 0.77 0.29 
80-89 0.93 0.20; 1.65 0.01 
Male (reference 
category: female) 
 
  
Male -0.16 -0.43; 0.11 0.25 
Education (reference 
category: no public 
examinations) 
 
  
Secondary examinations 0.38 0.05; 0.72 0.02 
Degree or higher 0.41 0.08; 0.75 0.02 
Collapse IMD** 
Score(reference 
category: bottom 50%) 
 
  
Top 50% -0.08 -0.29; 0.13 0.44 
Diagnosis (reference 
category: 
musculoskeletal origin) 
 
  
Neuropathic/vascular -0.36 -0.59; -0.13 <0.01 
Combined 0.23 -0.03; 0.49 0.08 
Duration of pain, years 
(reference category: <1 
year) 
 
  
1 - 4  0.57 0.24; 0.90 <0.01 
≥ 5 0.52 0.20; 0.84 <0.01 
Constant 4.79 4.16; 5.42 <0.01 
*Graded Chronic Pain Scale 
**Index of Multiple Deprivation 
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Table 3 Patients reporting employment in the Use of Services and Productivity 
Questionnaire over the 5 time points 
Time point  M0 (n=198) M6 (n=172) M12 (n=155) M18 (n=136) M24 (n=129)  
Number 
reporting 
being in 
employment 
(%) 
97 (48.99) 89 (51.74) 80 (51.61) 66 (48.53) 63 (48.84) 
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Table 4 Generalized Gamma Linear Regression Model (Log Link Function) of factors 
associated with indirect costs (352 observations over 5 time points) 
Variable Coefficient  
95% Confidence 
Interval 
P value 
Dichotomized  GCPS* 
state (low, 0 to IIa; 
high, IIb to IV) 
(reference category: Low 
GCPS)  
  
High GCPS 1.21 0.73 1.69 <0.01 
Time point (reference 
category: 0M)     
6M -0.14 -0.71 0.44 0.64 
12M -0.61 -1.23 0.00 0.05 
18M -0.28 -0.94 0.38 0.41 
24M -0.89 -1.54 -0.24 0.01 
Age Group, years 
(reference category: 20-
29)    
30-39 -0.27 -1.08 0.54 0.51 
40-49 -0.15 -0.98 0.68 0.72 
50-59 -0.20 -0.99 0.59 0.62 
60-69 -1.65 -2.62 -0.68 <0.01 
Male (reference 
category: female)    
Male 0.52 -0.10 1.13 0.10 
Education (reference 
category: no public 
examinations)    
Secondary examinations -0.81 -1.97 0.35 0.17 
Degree or higher -0.86 -2.05 0.33 0.16 
Collapse IMD** Score 
(reference category: 
bottom 50%)    
Top 50% 0.07 -0.39 0.53 0.77 
Diagnosis (reference 
category: 
musculoskeletal origin)    
Neuropathic/vascular 0.05 -0.44 0.54 0.85 
Combined 0.83 0.16 1.51 0.02 
Duration of pain, years 
(reference category: <1 
year)    
1 - 4  0.83 0.02 1.65 0.04 
≥ 5 0.54 -0.30 1.38 0.21 
Constant 6.93 5.58 8.28 <0.01 
*Graded Chronic Pain Scale 
**Index of Multiple Deprivation 
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